1.
Am Heart J
; 266: 179-183, 2023 12.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37567354
RESUMEN
We conducted this meta-analysis to compare expectant management of patent ductus arteriosus (PDA) with active treatment for PDA closure in preterm infants. Data from 7 randomized controlled trials (RCTs) showed that all-cause mortality and other clinical adverse outcomes did not differ between expectant management of PDA and active treatment. Future large-scale and double-blinded RCTs with a consistent definition for hemodynamically significant PDA, and focusing on clearly delineated high-risk subgroups or later selective treatment are needed to further evaluate the role of expectant management.
Asunto(s)
Conducto Arterioso Permeable , Recién Nacido , Humanos , Conducto Arterioso Permeable/terapia , Indometacina/uso terapéutico , Recién Nacido de Bajo Peso , Espera Vigilante , Ibuprofeno/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Recien Nacido Prematuro
2.
J Pak Med Assoc
; 74(6): 1205, 2024 Jun.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38949007